YKYY031
/ Youcare Pharmaceutical Group
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
August 22, 2026
YKYY031，tumors: Phase I Clinical Trial of YKYY031 for Injection in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=76 | Recruiting | Sponsor: Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Oncology • Solid Tumor • BRAF • FBXW7 • KRAS • PIK3CA • TP53
June 09, 2026
YKYY031，tumors: Phase I Clinical Trial of YKYY031 for Injection in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=76 | Not yet recruiting | Sponsor: Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
New P1 trial • Oncology • Solid Tumor • BRAF • FBXW7 • KRAS • PIK3CA • TP53
January 31, 2026
Phase I clinical trial of YKYY031 for injection in patients with advanced solid tumors
(ChiCTR)
- P1 | N=76 | Not yet recruiting | Sponsor: Beijing Cancer Hospital; Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
New P1 trial • Colorectal Cancer • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1